Applications of KinetiSol® Dispersing for the production of plasticizer free amorphous solid dispersions

European Journal of Pharmaceutical Sciences

Volumn 40, Issue 3, 2010, Pages 179-187

  DiNunzio, James C ^a   Brough, Chris ^b   Miller, Dave A ^a   Williams, Robert O ^a   McGinity, James W ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b DisperSol Technologies LLC   (United States)

Author keywords

Amorphous; Glass transition temperature; Hot melt extrusion; Itraconazole; KinetiSol Dispersing; Plasticizer; Solid dispersions; Stability

Indexed keywords

CARBOMER; CITRIC ACID TRIETHYL ESTER; EUDRAGIT; ITRACONAZOLE; PLASTICIZER; POLYMER; ACRYLIC ACID RESIN; DRUG CARRIER; EUDRAGIT L100 55; EUDRAGIT L100-55; EXCIPIENT;

ARTICLE; CHEMICAL COMPOSITION; CONTROLLED STUDY; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DIFFUSION; DISPERSION; DRUG MANUFACTURE; DRUG SOLUBILITY; DRUG STABILITY; IN VITRO STUDY; MICROSCOPY; PH; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SOLID STATE; THERMOGRAVIMETRY; X RAY DIFFRACTION; CHEMISTRY; DRUG FORMULATION; HEAT; METHODOLOGY; SYNTHESIS;

ACRYLIC RESINS; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG COMPOUNDING; DRUG STABILITY; EXCIPIENTS; HOT TEMPERATURE; ITRACONAZOLE; MICROSCOPY, ELECTRON, SCANNING; PLASTICIZERS; X-RAY DIFFRACTION;

EID: 77953028658     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2010.03.002     Document Type: Article

References (23)

1. Alder M., Pasch H., Meier C., Senger R., Koban H.-G., Augenstein M., Reinhold G. Molar mass characterization of hydrophilic copolymers. 1. Size exclusion chromatography of neutral and anionic (meth)acrylate copolymers. e-Polymers 2004, 55:1-16.
2. Andronis V., Zografi G. The molecular mobility of supercooled amorphous indomethacin as a function of temperature and relative humidity. Pharm. Res. 1998, 15(6):835-842.
3. Breitenbach J. Melt extrusion: from process to drug delivery technology. Eur. J. Pharm. Biopharm. 2002, 54(2):107-117.
4. Bruce C., Fegely K.A., Rajabi-Siahboomi A.R., McGinity J.W. Crystal growth formation in melt extrudates. Int. J. Pharm. 2007, 341(1-2):162-172.
5. Chiou W.L., Riegelman S. Pharmaceutical applications of solid dispersions. J. Pharm. Sci. 1971, 60(9):1281-1302.
6. ® Dispersing: A comparative study to hot melt extrusion. J. Pharm. Sci. 2010, 99(3):1239-1253.
7. DiNunzio J.C., Brough C., Williams R.O., McGinity J.W. Production of plasticizer free itraconazole solid dispersions for enhanced solid state properties using KinetiSol Dispersing - M1217. AAPS Annual Meeting and Exposition 2008.
8. DiNunzio J.C., Miller D.A., Yang W., McGinity J.W., Williams R.O. Amorphous compositions using concentration enhancing polymers for improved bioavailability. Mol. Pharm. 2008, 5(6):968-980.
9. Forster A., Hempenstall J., Tucker I., Rades T. Selection of excipients for melt extrusion with two poorly water-soluble drugs by solubility parameter calculation and thermal analysis. Int. J. Pharm. 2001, 226(1-2):147-161.
10. Hancock B.C. Disordered drug delivery: destiny, dynamics and the Deborah number. J. Pharm. Pharmacol. 2002, 54(6):737-746.
11. Hancock B.C. Amorphous pharmaceutical systems. Encyclopedia of Pharmaceutical Technology 2007, 83-91. Informa Healthcare USA, Hoboken, NJ. J. Swarbrick, J.C. Boylan (Eds.).
12. Hancock B.C., Shamblin S.L., Zografi G. Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures. Pharm. Res. 1995, 12(6):799-806.
13. Lin S.-Y., Yu H.-L. Thermal stability of methacrylic acid copolymers of Eudragits L, S, and L30D and the acrylic acid polymer of Carbopol. J. Polym. Sci. Part A: Polym. Chem. 1999, 37(13):2061-2067.
14. Miller D.A., DiNunzio J.C., Yang W., McGinity J.W., Williams R.O. Targeted intestinal delivery of supersaturated itraconazole for improved oral absorption. Pharm. Res. 2008, 25(6):1450-1459.
15. Miller D.A., DiNunzio J.C., Yang W., McGinity J.W., Williams R.O. Enhanced in vivo absorption of itraconazole via stabilization of supersaturation following acidic-to-neutral pH transition. Drug Dev. Ind. Pharm. 2008, 34(8):890-902.
16. Petereit H.-U., Weisbrod W. Formulation and process considerations affecting the stability of solid dosage forms formulated with methacrylate copolymers. Eur. J. Pharm. Biopharm. 1999, 47(1):15-25.
17. Rodríguez-Hornedo N., Kelly R.C., Sinclair B.D., Miller J.M. Crystallization: general principles and significance on product development. Encyclopedia of Pharmaceutical Technology 2007, 834-857. Informa Healthcare USA, Hoboken, NJ. J. Swarbrick, J.C. Boylan (Eds.).
18. Schilling S.U., Bruce C.D., Shah N.H., Malick A.W., McGinity J.W. Citric acid monohydrate as a release modifying agent in melt extruded matrix tablets. Int. J. Pharm. 2008, 361(1-2):158-168.
19. Shamblin S.L., Tang X., Chang L., Hancock B.C., Pikal M.J. Characterization of the time scales of molecular motion in pharmaceutically important glasses. JPCB 1999, 103(20):4113-4121.
20. Vasconcelos T., Sarmento B., Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov. Today 2007, 12(23-24):1068-1075.
21. Yu L. Amorphous pharmaceutical solids: preparation, characterization and stabilization. Adv. Drug Deliv. Rev. 2001, 48(1):27-42.
22. Zhou D., Zhang G.G.Z., Law D., Grant D.J.W., Schmitt E.A. Thermodynamics, molecular mobility and crystallization kinetics of amorphous griseofulvin. Mol. Pharm. 2008, 5(6):927-936.
23. Zhu Y., Shah N.H., Malick A.W., Infeld M.H., McGinity J.W. Solid-state plasticization of an acrylic polymer with chlorpheniramine maleate and triethyl citrate. Int. J. Pharm. 2002, 241(2):301-310.